SOPHiA GENETICS (SOPH) CSO Xu Zhenyu Sells 4,000 Shares

What Happened
Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), disposed of 4,000 shares on September 14, 2026. The filing reports a weighted average sale price of $7.88 per share for total proceeds of $31,538. The transaction is coded as a sale (S) and was executed as an open market or private sale per the Form 4.

Key Details

• Transaction date: 2026-09-14; Form 4 filed: 2026-09-16 (filed within the typical 2-business-day window).
• Shares sold: 4,000; weighted average price reported: $7.88; total proceeds: $31,538.
• Price range: sales occurred at prices between $7.78 and $7.99 (inclusive); the $7.88 is a weighted average. The filer offers to provide a breakdown of shares sold at each price on request (see footnote).
• Footnote: sale was made pursuant to a duly adopted Rule 10b5-1(c) trading plan (pre-arranged plan).
• Shares owned after the transaction: not disclosed in this filing.

Context
This was a sale executed under a 10b5-1 plan, which typically schedules trades in advance and reduces the inference that the insider timed the market. Sales (code S) are common and do not necessarily indicate negative views on the company; they are often routine or for personal liquidity. The filing appears timely based on the transaction and filing dates.